Ovarian Cancers
-15%
portes grátis
Ovarian Cancers
Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
Pujade-Lauraine, Eric; Lecuru, Fabrice; Ray-Coquard, Isabelle
Springer International Publishing AG
06/2018
286
Mole
Inglês
9783319811994
15 a 20 dias
615
Descrição não disponível.
PART 1: OVARIAN CANCER MANAGEMENTChapter 1. Clinical research in Europe dedicated to ovarian cancersE. Pujade-Lauraine, Paris, France
Chapter 2. Genetics of ovarian carcinomasClaire Senechal, Bruno Buecher, Antoine de Pauw, Claude Houdayer, Etienne Rouleau, Catherine Nogues, Dominique Stoppa-Lyonnet
Chapter 3. Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality Fabrice Lecuru, Charlotte Ngo, Anne Sophie Bats, Cherazade Bensaid, Pierre Combe, Eric Pujade Lauraine, Marie Aude le Frere Belda, Laure Fournier
Chapter 4. How to evaluate tumor burden before therapeutic decisionA. Fagotti, L. Pedone Anchora, M. Pacciani, G. Scambia
Chapter 5. Value of lymphadenectomyPhilipp Harter, Florian Heitz, Andreas du Bois
Chapter 6. HYPEC: what is the evidence? Jean-Marc Classe
Chapter 7. Onco-fertility applied to ovarian cancers
Enrica Bentivegna, Sebastien Gouy, Catherine Uzan, Marcos Ballester, Catherine Poirot, Emile Darai, Philippe Morice
Chapter 8. First-line systemic therapy (chemo/antiangiogenics) Sandro Pignata, Sabrina Cecere
Chapter 9.Elderly C. Falandry, Lyon, France
Chapter 10. Treatment at relapse (surgery & Systemic treatments)J. Pfisterer, A. Floquet
Chapter 11. The future in ovarian cancers & place of the new immunotherapies in ovarian cancersHolbrook E.K. Kohrt , Amani Makkouk, Cariad Chester
PART 2: PARTICULAR TYPES OF OVARIAN CANCERS (for each: histology and molecular specificities, specificity for surgery and management in first line and relapse)
Chapter 12. High Grade Carcinomas, BRCA mutations and the role of PARP inhibitorsJonathan A Ledermann
Chapter 13. Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or PeritoneumDavid M. Gershenson
Chapter 14. Clear Cell carcinomaMasashi Takano, Satoshi Takakura, Keiichii Fujiwara
Chapter 15. Endometrioid carcinoma Laure de Cock, Gerlinde Averous, Philippe Barthelemy, Jean-Emmanuel Kurtz
Chapter 16. Mucinous carcinomaJubilee Brown, MD Anderson
Chapter 17. Uterine and Ovarian CarcinosarcomaD. Berton-Rigaud, JS Frenel, I Ray-Coquard
Chapter 18. Malignant Ovarian Germ Cell Tumours; an overview of management and controversiesDr Costi Alifrangis, Professor Michael J Seckl
Garbi Annalisa, Achilarre Maria Teresa, Colombo Nicoletta
Chapter 20. Very rare ovarian malignant tumors including small cell carcinoma Patricia Pautier
Chapter 2. Genetics of ovarian carcinomasClaire Senechal, Bruno Buecher, Antoine de Pauw, Claude Houdayer, Etienne Rouleau, Catherine Nogues, Dominique Stoppa-Lyonnet
Chapter 3. Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality Fabrice Lecuru, Charlotte Ngo, Anne Sophie Bats, Cherazade Bensaid, Pierre Combe, Eric Pujade Lauraine, Marie Aude le Frere Belda, Laure Fournier
Chapter 4. How to evaluate tumor burden before therapeutic decisionA. Fagotti, L. Pedone Anchora, M. Pacciani, G. Scambia
Chapter 5. Value of lymphadenectomyPhilipp Harter, Florian Heitz, Andreas du Bois
Chapter 6. HYPEC: what is the evidence? Jean-Marc Classe
Chapter 7. Onco-fertility applied to ovarian cancers
Enrica Bentivegna, Sebastien Gouy, Catherine Uzan, Marcos Ballester, Catherine Poirot, Emile Darai, Philippe Morice
Chapter 8. First-line systemic therapy (chemo/antiangiogenics) Sandro Pignata, Sabrina Cecere
Chapter 9.Elderly C. Falandry, Lyon, France
Chapter 10. Treatment at relapse (surgery & Systemic treatments)J. Pfisterer, A. Floquet
Chapter 11. The future in ovarian cancers & place of the new immunotherapies in ovarian cancersHolbrook E.K. Kohrt , Amani Makkouk, Cariad Chester
PART 2: PARTICULAR TYPES OF OVARIAN CANCERS (for each: histology and molecular specificities, specificity for surgery and management in first line and relapse)
Chapter 12. High Grade Carcinomas, BRCA mutations and the role of PARP inhibitorsJonathan A Ledermann
Chapter 13. Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or PeritoneumDavid M. Gershenson
Chapter 14. Clear Cell carcinomaMasashi Takano, Satoshi Takakura, Keiichii Fujiwara
Chapter 15. Endometrioid carcinoma Laure de Cock, Gerlinde Averous, Philippe Barthelemy, Jean-Emmanuel Kurtz
Chapter 16. Mucinous carcinomaJubilee Brown, MD Anderson
Chapter 17. Uterine and Ovarian CarcinosarcomaD. Berton-Rigaud, JS Frenel, I Ray-Coquard
Chapter 18. Malignant Ovarian Germ Cell Tumours; an overview of management and controversiesDr Costi Alifrangis, Professor Michael J Seckl
Garbi Annalisa, Achilarre Maria Teresa, Colombo Nicoletta
Chapter 20. Very rare ovarian malignant tumors including small cell carcinoma Patricia Pautier
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Cancer therapeutics;Clinical research;Onco-fertility;Ovarian rare cancers;Quality of Life;surgical oncology
PART 1: OVARIAN CANCER MANAGEMENTChapter 1. Clinical research in Europe dedicated to ovarian cancersE. Pujade-Lauraine, Paris, France
Chapter 2. Genetics of ovarian carcinomasClaire Senechal, Bruno Buecher, Antoine de Pauw, Claude Houdayer, Etienne Rouleau, Catherine Nogues, Dominique Stoppa-Lyonnet
Chapter 3. Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality Fabrice Lecuru, Charlotte Ngo, Anne Sophie Bats, Cherazade Bensaid, Pierre Combe, Eric Pujade Lauraine, Marie Aude le Frere Belda, Laure Fournier
Chapter 4. How to evaluate tumor burden before therapeutic decisionA. Fagotti, L. Pedone Anchora, M. Pacciani, G. Scambia
Chapter 5. Value of lymphadenectomyPhilipp Harter, Florian Heitz, Andreas du Bois
Chapter 6. HYPEC: what is the evidence? Jean-Marc Classe
Chapter 7. Onco-fertility applied to ovarian cancers
Enrica Bentivegna, Sebastien Gouy, Catherine Uzan, Marcos Ballester, Catherine Poirot, Emile Darai, Philippe Morice
Chapter 8. First-line systemic therapy (chemo/antiangiogenics) Sandro Pignata, Sabrina Cecere
Chapter 9.Elderly C. Falandry, Lyon, France
Chapter 10. Treatment at relapse (surgery & Systemic treatments)J. Pfisterer, A. Floquet
Chapter 11. The future in ovarian cancers & place of the new immunotherapies in ovarian cancersHolbrook E.K. Kohrt , Amani Makkouk, Cariad Chester
PART 2: PARTICULAR TYPES OF OVARIAN CANCERS (for each: histology and molecular specificities, specificity for surgery and management in first line and relapse)
Chapter 12. High Grade Carcinomas, BRCA mutations and the role of PARP inhibitorsJonathan A Ledermann
Chapter 13. Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or PeritoneumDavid M. Gershenson
Chapter 14. Clear Cell carcinomaMasashi Takano, Satoshi Takakura, Keiichii Fujiwara
Chapter 15. Endometrioid carcinoma Laure de Cock, Gerlinde Averous, Philippe Barthelemy, Jean-Emmanuel Kurtz
Chapter 16. Mucinous carcinomaJubilee Brown, MD Anderson
Chapter 17. Uterine and Ovarian CarcinosarcomaD. Berton-Rigaud, JS Frenel, I Ray-Coquard
Chapter 18. Malignant Ovarian Germ Cell Tumours; an overview of management and controversiesDr Costi Alifrangis, Professor Michael J Seckl
Garbi Annalisa, Achilarre Maria Teresa, Colombo Nicoletta
Chapter 20. Very rare ovarian malignant tumors including small cell carcinoma Patricia Pautier
Chapter 2. Genetics of ovarian carcinomasClaire Senechal, Bruno Buecher, Antoine de Pauw, Claude Houdayer, Etienne Rouleau, Catherine Nogues, Dominique Stoppa-Lyonnet
Chapter 3. Debulking surgery: Interval debulking surgery vs primary: pro and con. How to evaluate quality Fabrice Lecuru, Charlotte Ngo, Anne Sophie Bats, Cherazade Bensaid, Pierre Combe, Eric Pujade Lauraine, Marie Aude le Frere Belda, Laure Fournier
Chapter 4. How to evaluate tumor burden before therapeutic decisionA. Fagotti, L. Pedone Anchora, M. Pacciani, G. Scambia
Chapter 5. Value of lymphadenectomyPhilipp Harter, Florian Heitz, Andreas du Bois
Chapter 6. HYPEC: what is the evidence? Jean-Marc Classe
Chapter 7. Onco-fertility applied to ovarian cancers
Enrica Bentivegna, Sebastien Gouy, Catherine Uzan, Marcos Ballester, Catherine Poirot, Emile Darai, Philippe Morice
Chapter 8. First-line systemic therapy (chemo/antiangiogenics) Sandro Pignata, Sabrina Cecere
Chapter 9.Elderly C. Falandry, Lyon, France
Chapter 10. Treatment at relapse (surgery & Systemic treatments)J. Pfisterer, A. Floquet
Chapter 11. The future in ovarian cancers & place of the new immunotherapies in ovarian cancersHolbrook E.K. Kohrt , Amani Makkouk, Cariad Chester
PART 2: PARTICULAR TYPES OF OVARIAN CANCERS (for each: histology and molecular specificities, specificity for surgery and management in first line and relapse)
Chapter 12. High Grade Carcinomas, BRCA mutations and the role of PARP inhibitorsJonathan A Ledermann
Chapter 13. Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or PeritoneumDavid M. Gershenson
Chapter 14. Clear Cell carcinomaMasashi Takano, Satoshi Takakura, Keiichii Fujiwara
Chapter 15. Endometrioid carcinoma Laure de Cock, Gerlinde Averous, Philippe Barthelemy, Jean-Emmanuel Kurtz
Chapter 16. Mucinous carcinomaJubilee Brown, MD Anderson
Chapter 17. Uterine and Ovarian CarcinosarcomaD. Berton-Rigaud, JS Frenel, I Ray-Coquard
Chapter 18. Malignant Ovarian Germ Cell Tumours; an overview of management and controversiesDr Costi Alifrangis, Professor Michael J Seckl
Garbi Annalisa, Achilarre Maria Teresa, Colombo Nicoletta
Chapter 20. Very rare ovarian malignant tumors including small cell carcinoma Patricia Pautier
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
